Metraipolis › archive › dc_0dcf1cae11cf

Serum levels of S100B in patients with chronic schizophrenia during treatment augmentation with sarcosine: results of the double-blind, randomized,… — Europe PMC PMID:41929255

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41929255
DOI
10.3389/fphar.2026.1705310
License (as archived)
solo-consultazione
Archived
2026-11-04T06:18:32.036Z
SHA-256 of the archived text
dfeed748a324a9cfd11465d826d113b1675470bcffc29eb4ceacdd6e3f7e9b4a
Stable URL of this page
https://metraipolis.com/documento/dc_0dcf1cae11cf

How to cite

Serum levels of S100B in patients with chronic schizophrenia during treatment augmentation with sarcosine: results of the double-blind, randomized,… — Europe PMC PMID:41929255 — Europe PMC (en), https://europepmc.org/article/MED/41929255 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0dcf1cae11cf (Metraipolis archive dc_0dcf1cae11cf, sha256 dfeed748a324a9cfd11465d826d113b1675470bcffc29eb4ceacdd6e3f7e9b4a)
BibTeX
@misc{dc0dcf1cae11cf,
  title = {Serum levels of S100B in patients with chronic schizophrenia during treatment augmentation with sarcosine: results of the double-blind, randomized,… — Europe PMC PMID:41929255},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41929255},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0dcf1cae11cf; sha256 dfeed748a324a9cfd11465d826d113b1675470bcffc29eb4ceacdd6e3f7e9b4a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41929255. Agents can read the archived copy with the MCP tool read_document.